Bio-On S.p.A. | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
278.00
4,066.00
8,640.00
4,055.60
40,944.90
Total Accounts Receivable
921.00
2,741.00
8,307.00
11,004.70
19,217.00
Other Current Assets
23.00
1.00
102.00
118.20
401.80
Total Current Assets
1,222.00
6,808.00
17,049.00
15,178.50
60,563.70
Net Property, Plant & Equipment
77.00
82.00
1,366.00
1,234.50
5,551.40
Total Investments and Advances
3.00
10.00
15.00
3.00
205.30
Long-Term Note Receivable
-
-
-
-
372.50
Intangible Assets
415.00
446.00
639.00
628.10
1,642.00
Other Assets
-
-
-
10.20
86.00
Total Assets
1,718.00
7,759.00
19,919.00
17,932.50
68,981.20
ST Debt & Current Portion LT Debt
-
219.00
339.00
325.20
1,797.10
Accounts Payable
637.00
1,091.00
852.00
1,100.50
2,216.60
Income Tax Payable
382.00
282.00
839.00
-
-
Other Current Liabilities
314.00
260.00
274.00
469.20
1,640.60
Total Current Liabilities
1,333.00
1,852.00
2,304.00
1,894.80
5,654.40
Long-Term Debt
-
126.00
656.00
385.40
14,922.00
Provision for Risks & Charges
30.00
40.00
1,160.00
1,144.30
936.80
Deferred Taxes
1.00
413.00
850.00
833.20
515.40
Total Liabilities
1,365.00
2,018.00
4,120.00
3,469.50
21,558.20
Common Equity (Total)
353.00
5,741.00
15,799.00
14,463.00
47,423.10
Total Shareholders' Equity
353.00
5,741.00
15,799.00
14,463.00
47,423.10
Total Equity
353.00
5,741.00
15,799.00
14,463.00
47,423.10
Liabilities & Shareholders' Equity
1,718.00
7,759.00
19,919.00
17,932.50
68,981.20

About Bio-On

View Profile
Address
Via Santa Margherita al Colle 10/3
Bologna Bologna 40016
Italy
Employees -
Website http://www.bio-on.it
Updated 09/14/2018
Bio-On SpA engages in the research, development, production, trade, design and maintenance of systems and components generated by renewable sources. It specializes in its proprietary process for the production of Polyhydroxyalkanoates under the MINERV-PHA brand. Its main activities include the characterization of new formulations and new biodegradable plastic materials to broaden the scope of use of PHAs and the research of new applications; the provision of feasibility and market studies; license grants to customers for the use of the technology; and the preparation of the process design package.